Protective action of 17β-estradiol and tamoxifen on glutamate toxicity in glial cells

International Journal of Developmental Neuroscience

Volumn 18, Issue 2-3, 2000, Pages 289-297

  Shy, Hogan ^a   Malaiyandi, Latha ^a   Timiras, Paola S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Estradiol; Glutamate toxicity; Proliferation; Survival death and differentiation of glial cells; Tamoxifen

Indexed keywords

ESTRADIOL; GLUTAMIC ACID; TAMOXIFEN; ANTIESTROGEN;

ANIMAL CELL; CELL DEATH; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY; GLIA CELL; GLIOMA CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; ARTICLE; CELL CULTURE; CELL DIVISION; CYTOLOGY; DRUG EFFECT; GLIA; GLIOMA;

ANIMALS; CELL DEATH; CELL DIFFERENTIATION; CELL DIVISION; CELL SURVIVAL; ESTRADIOL; ESTROGEN ANTAGONISTS; GLIOMA; GLUTAMIC ACID; NEUROGLIA; RATS; TAMOXIFEN; TUMOR CELLS, CULTURED;

EID: 0033621779     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-5748(99)00097-0     Document Type: Article

References (41)

1. Amano S., Ohashi M., Hishiko R., Hazama F. Humoral factors derived from glial cells protect cultured neuroblastoma cells against glutamate toxicity. Brain Res. 645:1994;347-350.
2. Ankarcrona M., Dypbukt J.M., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S.A., Nicotera P. Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function. Neuron. 15:1995;961-973.
3. Baas D., Dalecron D., Fressinaud C., Vitkovic L., Sarliere L.L. Oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells express glutamine synthetase; Development and cell-type-specific regulation. Mol. Psychiat. 3:1998;356-361.
4. Barkhem T., Andersson-Ross C., Höglund M., Nilsson S. Characterization of the "estrogenicity" of Tamoxifen and Raloxifene in HepG2 cells: Regulation of gene expression from an ERE controlled reported vector versus regulation of the endogenous SHBG and PS2 genes. J. Steroid Biochem. Mol. Biol. 62:1997;53-64.
5. Behl C., Skutella T., Lezoualch F., Post A., Widmann M., Newton C.J., Holsboer F. Neuroprotection against oxidative stress by estrogens: Structure-activity relationship. Mol. Pharmacol. 51:1997;535-541.
6. Bishop J., Simpkins J.W. Estradiol treatment increases viability of glioma and neuroblastoma cells in vitro. Mol. Cell Neurosci. 5:1994;303-308.
7. Chang D., Kwan J., Timiras P.S. Estrogens influence growth, maturation and amyloid β-peptide production in neuroblastoma cells and in a β-APP transfected kidney 293 cell line. Filogamo G., Vernadakis A., Gremo F., Privat A.M., Timiras P.S. Brain Plasticity, Development and Aging. 429:1997;261-271 Plenum Press, New York.
8. Couldwell W.T., Hinton D.R., He S.K., Chen T.C., Sebat I., Weiss M.H., Law R.E. Protein kinase C inhibitors induce apoptosis in human malignant glioma cell lines. FEBS Lett. 345:1994;43-46.
9. Couldwell W.T., Hinton D.R., Surnock A.A., Degiorgio C.M., Weiner L.P., Apuzzo M.L.J., Masri L., Law R.E., Weiss M.H. Treatment of recurrent malignant gliomas with chronic oral high-dose tamoxifen. Clin. Cancer Res. 2:1996;619-622.
10. DeGregorio M.W., Wiebe V.J. Tamoxifen and Breast Cancer. 1996;Yale University Press, New Haven.
11. Dugan L.L., Bruno V.M.G., Amagasu S.M., Giffard R.G. Glia modulate the response of murine cortical neurons to excitotoxicity: Glia exacerbate AMPA neurotoxicity. J. Neurosci. 15:1995;4545-4555.
12. Ericksson P.S., Perfilieva E., BjorkEriksson T., Alborn A.M., Nordborg C., Peterson D.A., Gage F.H. Neurogenesis in the adult human hippocampus. Nature Medicine. 4:1998;1313-1317.
13. Fischer B., Constantino J.P., Wickerham D.L., Remond C.K., Kavanah M., Cronin W.M., Vogel V., Robidoux A., Dimitrov N., Atkins J., Daly M., Wieand S., TanChiu E., Ford L., Wolmark N. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J. Natl. Cancer Inst. 90:1998;1371-1388.
14. Giacobini E. Aging, Alzheimer's disease and estrogen therapy. Exp. Gerontol. 33:1998;865-869.
15. Goodman Y., Bruce A.J., Cheng B., Mattson M.P. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury and amyloid β-peptide toxicity in hippocampal neurons. J. Neurochem. 66:1996;1836-1844.
16. Gray C.W., Patel A.J. Neurodegeneration mediated by glutamate and β-amyloid peptide: a comparison and possible interaction. Brain Res. 691:1995;169-179.
17. Green P.S., Gridley K.E., Simpkins J.W. Estradiol protects against β-amyloid (25-35)-induced toxicity in SK-N-SH human neuroblastoma cells. Neurosci. Lett. 218:1996;165-168.
18. Han D., Sen C.K., Roy S., Kobayashi M.S., Tritschler H.J., Packer L. Protection against glutamate-induced cytotoxicity in C6 glial cells by thiol antioxidants. Am. J. Physiol. 273:1997;R1771-R1778.
19. Hashimoto M., Inoue S., Muramatsu M., Masliah E. Estrogen stimulate tamoxifen-induced neuronal cell apoptosis in vitro: A possible nongenomic action. Biochem. Biophys. Res. Commun. 240:1997;464-470.
20. Higashigawa K.H., Vorgas D., Timiras P.S. Effects of estradiol and selective estrogen receptor modulators on proliferation and enzyme activity of glial cells. Exp. Gerontol. 33:1998;913.
21. Jung-Testas I., Baulieu E.E. Steroid hormone receptors and steroid action in rat glial cells of the central and peripheral nervous system. J. Steroid Biochem. Mol. Biol. 65:1998;243-251.
22. Jung-Testas I., Schumacher M., Robel P., Baulieu E.E. Actions of steroid hormones and growth factors on glial cells of the central and peripheral nervous system. J. Steroid Biochem. Mol. Biol. 48:1994;145-154.
23. Kapur R., Timiras P.S. Estrogen-brain relationship during development and aging: effects on glial cells. Neuroendocrinol. Lett. 18:1997;215-220.
24. Kentroti S., Vernadakis A. Plasticity of astrocytes in culture. Vernadakis A., Roots B. Neuron-glia Interrelations During Phylogeny. II: Plasticity and Regeneration. 1995;439-478 Humana Press Inc, Totowa, NJ.
25. MacGregor J.I., Jordan V.C. Basic guide to the mechanisms of antiestrogen action. Pharmacol. Rev. 50:1998;151-196.
26. McEwen B.S. Oestrogens and the structural and functional plasticity of neurons: Implications for memory, aging and neurodegenerative diseases. Bock G.J., Goode J.A. CIBA Foundation Symposium, Non-reproductive Actions of Sex Steroids. 1995;52-73 John Wiley and Sons, Ltd, New York. Vol. 191.
27. Mitlak B.H., Cohen F.J. In search of optimal long-term female hormone replacement therapy: The potential of selective estrogen receptor modulators. Horm. Res. 48:1997;155-163.
28. Navarro D., Leon L., Chirino R., Fernandez L., Pestano J., DiazChico B.N. The two native estrogen receptor forms of 8 s and 4 s present in cytosol from human uterine tissue display opposite reactivities with the antiestrogen tamoxifen aziridine and the estrogen responsive element. J. Steroid Biochem. Mol. Biol. 64:1998;49-58.
29. Paech K., Webb P., Kuiper G., Nilsson S., Gustafsson J.A., Kushner P.J., Scanlan T.S. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science. 277:1997;1508-1510.
30. Parker K.K., Norenberg M.D., Vernadakis A. "Transdifferentiation" of C-6 glial cells in culture. Science. 208:1980;179-181.
31. Santagati S., Melcangi R.C., Celotti F., Martini L., Maggi A. Estrogen receptor is expressed in different types of glial cells in culture. J. Neurochem. 63:1994;2058-2064.
32. Sass J.B., Ang L.C., Juurlink B.H.J. A simple yet versatile co-culture method for examining neuron-glia interactions. J. Neurosci. Methods. 47:1993;115-121.
33. Schousboe A., Westergaard N., Sonnewald W., Petersen S.B., Huang R., Peng L., Hertz L. Glutamate and glutamine metabolism and compartmentation in astrocytes. Dev. Neurosci. 15:1993;359-366.
34. Singer C.A., Rogers K.L., Strickland T.M., Dorsa D.M. Estrogen protects primary cortical neurons from glutamate toxicity. Neurosci. Lett. 212:1996;13-16.
35. Smalheiser N.R., Swanson D.R. Linking estrogen to Alzheimer's disease: an informatics approach. Neurology. 47:1996;809-810.
36. Syková E. The extracellular space in the CNS: its regulation, volume and geometry in normal and pathological neuronal function. Neuroscientist. 3:1997;28-41.
37. Tang M.X., Jacobs D., Stern Y., Marder K., Schofield P., Gurland B., Andrews H., Mayeux R. Effect of oestrogen during menopause on risk of age of onset of Alzheimer's disease. Lancet. 348:1996;429-432.
38. Toran-Allerand C.D., Miranda R.C., Bentham W.D.L., Sohrabji F., Brown T.J., Hochberg R.B., Maclusky N.J. Estrogen receptors co-localize with low affinity NGF receptors in cholinergic neurons of the basal forebrain. Proc. Natl. Acad. Sci. USA. 89:1992;4668-4672.
39. Vernadakis A. Glia-neuron intercommunications and synaptic plasticity. Prog. Neurobiol. 49:1996;185-214.
40. Veronesi U., Maisonneuve P., Costa A., Sacchini V., Maltoni C., Robertson C., Rotmensz N., Boyle P. Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Lancet. 352:1998;93-97.
41. Wiseman H. Tamoxifen: New membrane-mediated mechanisms of action and therapeutic advances. TiPS (Trends in Pharmacological Sciences). 15:1994;83-89.